Physician profile
Anna N Hunter
NPI 1649243171
$274.52
in general payments reported to CMS, 2019-2025
10 companies · $53.80 in 2025
The $53.80 reported for 2025 was less than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $54.47 · 2023: $98.52 · 2024: $67.73 · 2025: $53.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $220.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $54.62 | 2024 | Paragard T 380a, Endosee |
| Exeltis, USA INC. | $53.04 | 2023-2025 | Slynd |
| Axonics, INC. | $41.14 | 2022-2023 | Axonics |
| Sumitomo Pharma America, INC. | $29.27 | 2023 | Myfembree |
| Exact Sciences Corporation | $22.52 | 2025 | Cologuard Collection Kit |
| Gynesonics, INC. | $16.33 | 2022 | |
| Myovant Sciences INC. | $15.71 | 2022 | |
| Sage Therapeutics, LLC | $15.18 | 2025 | Zurzuvae |
| Abbvie INC. | $13.60 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.11 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.